These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 19755453)

  • 1. Guidance for handling and use of nanomaterials at the workplace.
    Heinemann M; Schäfer HG
    Hum Exp Toxicol; 2009 Jun; 28(6-7):407-11. PubMed ID: 19755453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice.
    Kuempel ED; Geraci CL; Schulte PA
    Ann Occup Hyg; 2012 Jul; 56(5):491-505. PubMed ID: 22752094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for assessing workplace exposures to nanomaterials.
    Ramachandran G; Ostraat M; Evans DE; Methner MM; O'Shaughnessy P; D'Arcy J; Geraci CL; Stevenson E; Maynard A; Rickabaugh K
    J Occup Environ Hyg; 2011 Nov; 8(11):673-85. PubMed ID: 22023547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.
    Tinkle SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):88-98. PubMed ID: 20049833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations.
    Lee J; Mahendra S; Alvarez PJ
    ACS Nano; 2010 Jul; 4(7):3580-90. PubMed ID: 20695513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T; Bahadori T; Savage N; Thomas K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing adoption of precautionary risk management guidance for nanomaterials, an emerging occupational hazard.
    Schubauer-Berigan MK; Dahm MM; Schulte PA; Hodson L; Geraci CL
    J Occup Environ Hyg; 2015; 12(1):69-75. PubMed ID: 25093252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASH--an innovative approach to sustainable OSH improvement at workplace.
    Pingle S; Shanbhag S
    Med Lav; 2006; 97(2):358-67. PubMed ID: 17017372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs.
    Iavicoli S; Rondinone BM; Boccuni F
    Hum Exp Toxicol; 2009 Jun; 28(6-7):433-43. PubMed ID: 19755456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology: are occupational health nurses ready?
    McCauley LA; McCauley RD
    AAOHN J; 2005 Dec; 53(12):517-21. PubMed ID: 16401058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How safe is control banding? Integrated evaluation by comparing OELs with measurement data and using monte carlo simulation.
    Tischer M; Bredendiek-Kämper S; Poppek U; Packroff R
    Ann Occup Hyg; 2009 Jul; 53(5):449-62. PubMed ID: 19531808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
    Som C; Nowack B; Krug HF; Wick P
    Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials.
    Franco A; Hansen SF; Olsen SI; Butti L
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):171-83. PubMed ID: 17509740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workplace practices for engineered nanomaterial manufacturers.
    Woskie S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):685-92. PubMed ID: 20593453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.